SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities [amend]
SEC Accession No. 0001209191-09-006294
Filing Date
2009-02-03
Accepted
2009-02-03 18:05:02
Documents
1
Period of Report
2009-01-22
Filing Date Changed
2009-02-03

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 3992
  Complete submission text file 0001209191-09-006294.txt   5793
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address 6455 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 8586466649
Elchico Josefina T (Reporting) CIK: 0001305820 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-24274 | Film No.: 09566129